Caliway Biopharmaceuticals
6919.TW
#3103
Rank
A$7.21 B
Marketcap
A$4.63
Share price
-3.24%
Change (1 day)
3.19%
Change (1 year)

Financial Statements

Thumbnail Caliway Biopharmaceuticals Financial Statement 2025-h1

Financial Statement 2025-h1

Language: English

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2025-h1

Financial Statement 2025-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2024-h1

Financial Statement 2024-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2024

Financial Statement 2024

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2023-h1

Financial Statement 2023-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2023

Financial Statement 2023

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2022-h1

Financial Statement 2022-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2022

Financial Statement 2022

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2021

Financial Statement 2021

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2020

Financial Statement 2020

Language: Chinese

View Financial Statement